Multiple Sclerosis , The Patient Education Institute, Inc. nr Last reviewed: 04/17/2017 1

Similar documents
Multiple Sclerosis. Brain Spinal Cord. Peripheral Nerves

Do you or did you have any family members who have been diagnosed with MS? Yes No I Don t Know. Yes identical Yes not identical No

What is Multiple Sclerosis? Gener al information

MULTIPLE SCLEROSIS INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

MULTIPLE SCLEROSIS - REVIEW AND UPDATE

Multiple Sclerosis. What is multiple sclerosis? What is the cause? What are the symptoms?

Multiple Sclerosis. What types of MS are there? 4 There are 4 types of MS.

Progress in MS: Current and Emerging Therapies. Presented by: Dr. Kathryn Giles, MD MSc FRCPC Cambridge, Ontario, Canada

Multiple sclerosis. Tünde Csépány MD. PhD. 08. November 2017.

Multiple Sclerosis. Biology 12 Nervous System Project

Frequently Asked Questions For persons with multiple sclerosis

Le Hua, MD. Disclosures Teaching and Speaking: Teva Neurosciences, Genzyme, Novartis Advisory Board: Genzyme, EMD Serono

Biologics and Beyond: Treatment of Multiple Sclerosis. Rita Jebrin, PharmD, BCPS

Get on with life, we ll see you. in 6 months. Living your life your way with MS

Multiple sclerosis. Tünde Csépány MD. PhD

Advances in the Management of Multiple Sclerosis: A closer look at novel therapies. Disclosures

Medication Policy Manual. Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013

APPENDIX D SASKATCHEWAN MS DRUGS PROGRAM

Anticipated Launches Q Q1 2019

Relapses Matter A GUIDE TO REPORTING MULTIPLE SCLEROSIS SYMPTOMS

Understanding your Tecfidera. treatment. Information for patients who have been prescribed treatment with Tecfidera.

Prof. Dimitrios Karussis Director of the Hadassah Center for MS

A Case Study: Multiple Sclerosis. Kayla Jensen February 2013

Multiple Sclerosis. By: Selena Fucci April 22, 2016

Pediatric MS treatments: What do you start with, when do you switch?

While MS sometimes causes severe disability, it is only rarely fatal and most people with MS have a normal life expectancy.

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

AMPYRA (dalfampridine) extended release oral tablet Dalfampridine ER oral tablet

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Pharmacy Management Drug Policy

Regulatory Status FDA-approved indication: Tysabri is an integrin receptor antagonist indicated for treatment of (1):

About MS. An Overview of Multiple Sclerosis (MS), Including Symptoms, Treatments, and Research

DOWNLOAD OR READ : MULTIPLE SCLEROSIS THE HISTORY OF A DISEASE PDF EBOOK EPUB MOBI

Multiple Sclerosis Diagnosis And Therapy

Mitzi Joi Williams, MD Neurologist MS Center of Atlanta Atlanta, GA

Clinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:

387

Committee Approval Date: December 12, 2014 Next Review Date: December 2015

Regulatory Status FDA-approved indication: Tysabri is an integrin receptor antagonist indicated for treatment of:

The Impact of Multiple Sclerosis in the. James Bowen, MD Multiple Sclerosis Center

Clinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:

MEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease

See Important Reminder at the end of this policy for important regulatory and legal information.

Pre-Return Visit Questionnaire for Multiple Sclerosis

SUBHAN ALLAH US/CANADIAN PHARMACY EXAMS EDNAN UNDERSTANDING MULTIPLE SCLEROSIS (MS) COPY RIGHT PROTECTED Page 1

NARCOMS Tremor and Ataxia Questionnaire

EMA confirms recommendations to minimise risk of brain infection PML with Tysabri

TREATING MULTIPLE SCLEROSIS The Current Disease Modifying Therapies Beverly Gilder, M.D. Blue Sky Neurology MS Center

Rheumatoid Arthritis

MS Treatments Aubagio TM

Clinical Policy: Mitoxantrone (Novantrone) Reference Number: CP.CPA.334 Effective Date: Last Review Date: Line of Business: Commercial

AUBMC Multiple Sclerosis Center

Originally published December 2, Revisions and re-print November 2012.

Page 1. Multiple Sclerosis. I have no conflicts of interest. Team Menstrual Cycles Waves to Wine for MS. Overview.

What it is used for. What TYSABRI is used for

Horizon Scanning Centre July Ocrelizumab for relapsing-remitting multiple sclerosis SUMMARY NIHR HSC ID: 3711

Objectives. There Aren t Enough Hours in the Day

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow

GILENYA (fingolimod) oral capsule

Cascadia Chiropractic Centre

Investor Update. Downloads. Services PDF. Basel, 17 July 2017

MAVENCLAD. (cladribine tablets) MS Treatments. Produced by Lind Publishing, Inc.

Clinical Policy: Mitoxantrone (Novantrone) Reference Number: CP.PHAR.258 Effective Date: Last Review Date: Line of Business: Medicaid

Clinical Case Study Discussion of Demyelinating Diseases. Mirela Cerghet, MD, PhD Henry Ford Hospital August 6, 2011

X-Plain Seizures And Epilepsy Reference Summary

Is Yoga Effective in Reducing Fatigue in Patients With Multiple Sclerosis?

The Nervous System. We have covered many different body systems which automatically control and regulate our bodies.

NEW PATIENT FORM UPMC Neurology Department Drs. Heyman, Zaydan, Xia, and Mr. Ryan Orie

TYSABRI (tie-sa-bree)

Choices. Disease modifying treatments. Read me

Clinical Policy: Natalizumab (Tysabri) Reference Number: ERX.SPA.162 Effective Date:

MS Learn Online. and. Holly: this time. for others. >>Kate

Local Natalizumab Treatment Protocol

Mercy MS Center New Patient Information

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

MRI Spine - FAX Evaluate Neck/Back pain

Clinical Policy: Natalizumab (Tysabri) Reference Number: CP.PHAR.259 Effective Date: Last Review Date: Line of Business: Medicaid

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

For all requests for Multiple Sclerosis Medications all of the following criteria must be met:

* CC* PATIENT QUESTIONNAIRE

Welcome to today s webinar: Learn about MS

Depression management: Emotional Disorders in Multiple Sclerosis

Biology 3201 Nervous System # 7: Nervous System Disorders

Treating MS. New medicines, strong evidence, better practice? September 2015

Spinal Cord Injury. The nerves that go from the spinal cord to the arms, legs, chest, and abdomen are called peripheral nerves.

Medications to Slow Multiple Sclerosis Progression Multiple sclerosis disease-modifying medications

Chronic Inflammatory Demyelinating Polyneuropathy (C.I.D.P.)

TECFIDERA (dimethyl fumarate) oral capsule

presents How to S.E.A.R.C.H. for the Right MS Therapy for You! G Live Webinar October 19, 2016

Facet Joint Syndrome / Arthritis

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

Disease-modifying therapies

Problems of Neurological Function. Unit 10

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

Immune Modulating Drugs Prior Authorization Request Form

See Important Reminder at the end of this policy for important regulatory and legal information.

Inner Ear Disorders. Information for patients and families

Roche s OCREVUS (ocrelizumab) approved in Switzerland for primary progressive and relapsing forms of multiple sclerosis

Fingolimod (Gilenya) What is fingolimod? Can I have this drug?

Transcription:

Multiple Sclerosis Introduction Multiple sclerosis, or MS, is a disease of the brain and spinal cord. Most patients with multiple sclerosis are able to lead a very functional life. However, MS causes a handicap for some patients. This reference summary will help you understand what multiple sclerosis is and how it can be treated. It also discusses symptoms and causes of MS. Anatomy The brain is the command center of the body. In addition to thinking and feeling, it receives information and sends orders to different parts of the body. Orders from the brain travel through the spinal cord. From the spinal cord, orders travel to the rest of the body through peripheral nerves. Together, the brain and spinal cord are called the central nervous system. The nerves in the rest of the body are called the peripheral nervous system. Different areas of the brain control different functions. For example, specific areas of the brain control vision, motions, touch, hearing, and thinking. Like other tissue in the body, the brain is made of cells. The cells of the brain and nerves are called neurons. Each neuron has a body and an axon. Axons are long fibers that are similar to electrical wires. Though neurons are microscopic, the axons can extend from the brain to the hand! Neurons communicate with each other by sending electrical signals through the axons. For instance, a nerve in the finger may sense heat, and send the message to the brain through axons. The brain would then send 1

orders to the muscles to move the finger. Voluntary muscles are directly controlled by nerves, which receive orders from the brain. A special material called myelin covers axons. Myelin improves the conduction of the electric current and communication between neurons. In multiple sclerosis, the myelin in certain parts of the brain, spinal cord, or central nervous system is destroyed. Scientists currently do not know why this myelin is destroyed. Multiple Sclerosis It is then destroyed, forming a scar over the axons. Sclerosis means scar. When myelin is destroyed, the neurons communicate less effectively, causing the symptoms of multiple sclerosis. For instance, if the Myelin myelin of vision neurons is destroyed, vision is affected. If the myelin of muscle neurons is destroyed, the muscle becomes weak. Some myelin destruction repairs itself, which is why most people improve after an attack of MS. However, myelin can become inflamed again at different times and in different places. There are two types of multiple sclerosis. The most common type is relapsing remitting MS, which affects 85% of patients with MS. It is characterized by periods of worsening symptoms followed by periods of improvement. The other type is called progressive MS, meaning that the disease keeps on getting worse without any improvement. About 60% of the patients with the first type of relapsing remitting MS end up having the progressive type within 15 years if they are not treated. Multiple sclerosis usually appears in Caucasian people between the ages of 15 and 60. Women are affected two to three times as often as men. 2

People who live in temperate climates are more likely to develop MS than those living in tropical areas. Mild climates include the northern United States, Canada, and Europe. Causes Scientists do not know what causes the destruction of myelin in multiple sclerosis. Some scientists believe that cells of the immune system attack the myelin in the central nervous system. The immune system usually attacks germs and foreign bodies. Cells of the immune system may be attacking myelin in MS because they mistake it for a foreign, harmful material. This type of disease is called an autoimmune disease. Some researchers think that after certain types of viral infections, the immune system starts attacking the myelin of the central nervous system as if it were the virus. There may also be genetic causes of MS because certain populations are more or less susceptible to it. For example, Native Americans have a very low incidence of it. This leads to the idea that MS may be partially hereditary. In studies of identical twins, only about 30% of twins of patients with MS developed MS. This shows that even though there is a genetic component, this component is not the only reason for developing MS. Signs & Symptoms Symptoms of MS depend on the area of the central nervous system that loses myelin. Early symptoms may include: numbness or tingling in parts of the body, usually the leg or arm unexplained weakness, dizziness, and fatigue double vision, blurry vision, or blindness 3

During periods of remission, the patient may feel better, but the arm or leg may feel stiff. Some weakness, numbness, and vision problems may remain. As the symptoms come back, they may become more severe and include: muscle spasms bowel and bladder problems slurred speech blindness sexual problems paralysis confusion and forgetfulness Pain can also be a symptom of MS, it can involve the face or one of the extremities. In some patients, heat seems to make symptoms worse. Such patients should avoid long hot baths or being outside too long on hot days. The symptoms of MS can be found in other diseases. This means that not all patients with the symptoms of MS have MS. Diagnosis Physical examination and medical history are very important in diagnosing MS. Physical exams include a variety of tests to check the health of the nerves and muscles. A diagnosis of MS relies primarily on seeing patches of destroyed myelin on a magnetic resonance imaging (MRI) scan. As the doctor tracks the progress of the disease, multiple MRIs may need to be done. MRIs also help make sure that the patient is not suffering from other diseases that have symptoms similar to MS, such as brain tumors and disk herniations in the neck or lower back. 4

Spinal fluid may be taken from the back to test for abnormalities. Other tests aim at measuring the speed of the brain connections. For example, the Visual Evoked Response test measures the speed of the visual pathway. The Brain Stem Evoked Response test measures the speed of the auditory, or hearing, pathways. Your doctor may ask for other tests to determine if diseases other than MS are causing symptoms similar to those of MS. For example, some vitamin deficiencies have early symptoms that resemble those of MS. Treatment Scientists have not discovered a cure for MS yet. However, several medications are available to help control the disease. Doctors and scientists are constantly finding out new things about MS and about how to treat and manage it. The specific treatment recommendations for each patient with MS depend on the patient s condition, his or her type of MS, how debilitating it is and how progressive it is. For patients who find out that they have MS unexpectedly after an MRI, when they ve had no recent symptoms or active disease, treatment may not be necessary. However, these patients should be watched closely just in case the MS flares up. Patients with ongoing flare ups and symptoms may be prescribed a variety of medications to control the progress of MS. Such medications may reduce the severity of the symptoms or decrease how often they occur. Special chemicals that help regulate the immune system can be used to treat MS. These are known as Beta interferons. These formulations have been approved by the FDA: Betaseron Avonex Rebif Extavia Plegridy 5

Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability. When attacks do occur, they tend to be shorter and less severe. These medications are given by injection under the skin or into a large muscle. They are usually injected one or more times a week. Plegridy is injected every two weeks. The side effects of these interferons include: symptoms of cold, depression, increase in spasticity, and possible abnormalities in liver function tests or blood counts. Fingolimod (Gilenya ) is an immunosuppressive medication taken by mouth. It was shown to reduce MS attacks and decrease disability. However, it has some potentially dangerous side effects, such as a slow heart rate, vision and liver problems, among others. Strict follow up and supervision by a healthcare provider is a must. Aubagio (teriflunomide) and Tecfidera (dimethyl fumarate) are medications taken by mouth that reduce inflammation and affect the activity of the immune system. Ask your healthcare provider for more information about possible side effects and risks of these medications. The FDA also has approved a synthetic form of myelin basic protein, called copolymer I (Copaxone or Glatopa ), for the treatment of relapsing-remitting MS. Copolymer I has few side effects, and studies indicate that the agent can reduce the relapse rate by almost one third. Novantrone (mitoxantrone) is an anticancer drug that weakens the immune system. By weakening the immune system it decreases the symptoms of MS. It is given intravenously once every three months. It is very well tolerated except for some nausea and vomiting that can be treated at the time of the injection. One of its side effects is possible damage to the heart. This occurs after a certain dosage of the medication has been given. Most patients can take it safely for up to two years. 6

Other anticancer medications have been tried. These include cyclosporine (Sandimmune ), cyclophosphamide (Cytoxan ), methotrexate and azathioprine (Imuran ). Bone marrow transplant is also being studied as a treatment for MS. The FDA has also approved dalfampridine (Ampyra ) to improve walking in individuals with MS. One monoclonal antibody, natalizumab (Tysabri ), was shown in clinical trials to significantly reduce the frequency of attacks in people with relapsing forms of MS and was approved for marketing by the U.S. Food and Drug Administration (FDA) in 2004. However, in 2005 the drug s manufacturer voluntarily suspended marketing of the drug after several reports of significant adverse events. In 2006, the FDA again approved sale of the drug for MS but under strict treatment guidelines involving infusion centers where patients can be monitored by specially trained physicians. Steroids, given either orally or intravenously, can help decrease the severity of an attack. It is not known whether they can help a patient have fewer attacks or not. Steroids sometimes used include methylprednisolone, prednisone and ACTH. There are a lot of ways to treat MS and the treatment methods change all the time as we keep learning more. This is why it is very important to check with your physicians frequently about any new developments in this ever evolving and thankfully improving field. Many clinical trials are under way to help patients who need better control of their MS. Researchers are currently studying stem cell therapies to slow disease activity and repair existing damage to the nervous system. Ask your healthcare provider for more information on stem cell research. Other medications aim at improving neurological problems. For example, medication can be used to decrease the stiffness of the muscles. These include: Baclofen (Lioresal ) Tizanidine (Zanaflex ) Diazepam (Valium ) Clonazepam (Klonopin ) Dantrolene (Dantrium ) 7

Physical therapy and exercise can help preserve remaining function, and patients may find that various aids -- such as foot braces, canes, and walkers -- can help them remain independent and mobile. Avoiding excessive activity and avoiding heat are probably the most important measures patients can take to counter physiological fatigue. If psychological symptoms of fatigue such as depression or apathy are evident, antidepressant medications may help. Other drugs that may reduce fatigue in some, but not all, patients include amantadine (Symmetrel ), pemoline (Cylert ). Although improvement of optic symptoms usually occurs even without treatment, a short course of treatment with intravenous methylprednisolone (Solu-Medrol ) followed by treatment with oral steroids is sometimes used. Adopting healthy life habits helps MS patients cope with fatigue and potential stress caused by MS. These habits include: getting enough rest exercising regularly eating a healthy, balanced diet with lots of fiber relaxation and reducing stress in your life 8

Summary Multiple sclerosis is a disease of the brain and spinal cord. It can be debilitating, however, most people with MS are able to lead normal, active lives and pursue their hobbies. If you have symptoms of MS, such as numbness or tingling in any part of your body, check with your doctor. Other symptoms of MS include double vision, blindness, muscle tremor, fatigue, and dizziness. MS can be treated with medication. Some cases of MS are benign and only need to be observed without any treatment. Keeping healthy life habits and staying connected with friends and family are great ways to cope with multiple sclerosis and limit the fatigue and stress it may place on the body. 9